Stella Pharma (4888) · TargetRestated
Goal of providing Steboronin (a drug) as the “world’s first drug originating in Japan”
First written in FY2021. 1 of 2 entries say "Restated". Latest entry: FY2022.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Goal of providing Steboronin (a drug) as the “world’s first drug originating in Japan”A theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2022RestatedAnnual report
「While maintaining this competitive advantage, the Company will pursue its business with the goal of providing Steboronin® to the medical community as the “world’s first, originating in Japan” pharmaceutical.」
The Company continues to pursue the goal of offering Steboronin as the “world’s first, originating in Japan” pharmaceutical. - FY2021First statedAnnual report
「While maintaining this competitive advantage, the Company will pursue its business with the goal of providing Steboronin® to the medical community as the “world’s first, originating in Japan” pharmaceutical.」
The Company describes its approved product as a “world’s first, originating in Japan” pharmaceutical to be provided to the medical community.